{"address1": "777 Old Saw Mill River Road", "city": "Tarrytown", "state": "NY", "zip": "10591-6707", "country": "United States", "phone": "914 847 7000", "website": "https://www.regeneron.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.", "fullTimeEmployees": 13450, "companyOfficers": [{"maxAge": 1, "name": "Dr. Leonard S. Schleifer M.D., Ph.D.", "age": 70, "title": "Co-Founder, President, CEO & Co-Chairman", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": 7004069, "exercisedValue": 0, "unexercisedValue": 256815824}, {"maxAge": 1, "name": "Dr. George D. Yancopoulos M.D., Ph.D.", "age": 63, "title": "Co-Founder, President, Chief Scientific Officer & Co-Chairman", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 6593696, "exercisedValue": 0, "unexercisedValue": 242710064}, {"maxAge": 1, "name": "Dr. Andrew J. Murphy Ph.D.", "age": 64, "title": "Executive Vice President of Research", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 1622950, "exercisedValue": 19388300, "unexercisedValue": 83458888}, {"maxAge": 1, "name": "Mr. Daniel P. Van Plew", "age": 50, "title": "Executive VP and GM of Industrial Operations & Product Supply", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 1954399, "exercisedValue": 45282380, "unexercisedValue": 24788798}, {"maxAge": 1, "name": "Ms. Marion E. McCourt", "age": 63, "title": "Executive Vice President of Commercial", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 1500262, "exercisedValue": 4246309, "unexercisedValue": 8790830}, {"maxAge": 1, "name": "Mr. Christopher R. Fenimore CPA", "age": 52, "title": "Senior VP of Finance & CFO", "yearBorn": 1971, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Patrice  Gilooly", "title": "Senior Vice President of Quality Assurance & Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bob  McCowan", "title": "Senior VP of IT & Chief Information Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Crowe", "title": "Senior Vice President of Investor Relations & Strategic Analysis", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph J. LaRosa", "age": 64, "title": "Executive VP, General Counsel & Secretary", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 1748110, "exercisedValue": 23227300, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 966.96, "open": 974.75, "dayLow": 968.0, "dayHigh": 979.255, "regularMarketPreviousClose": 966.96, "regularMarketOpen": 974.75, "regularMarketDayLow": 968.0, "regularMarketDayHigh": 979.255, "beta": 0.11, "trailingPE": 27.880472, "forwardPE": 20.478315, "volume": 427433, "regularMarketVolume": 427433, "averageVolume": 532156, "averageVolume10days": 473830, "averageDailyVolume10Day": 473830, "bid": 967.06, "ask": 969.94, "bidSize": 100, "askSize": 100, "marketCap": 106250715136, "fiftyTwoWeekLow": 684.81, "fiftyTwoWeekHigh": 998.33, "priceToSalesTrailing12Months": 8.100106, "fiftyDayAverage": 953.289, "twoHundredDayAverage": 839.73737, "currency": "USD", "enterpriseValue": 95769452544, "profitMargins": 0.30141002, "floatShares": 102752916, "sharesOutstanding": 107944000, "sharesShort": 1357070, "sharesShortPriorMonth": 1250252, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0124, "heldPercentInsiders": 0.02582, "heldPercentInstitutions": 0.89189005, "shortRatio": 2.65, "shortPercentOfFloat": 0.0147, "impliedSharesOutstanding": 109762000, "bookValue": 242.472, "priceToBook": 3.9922547, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "earningsQuarterlyGrowth": -0.031, "netIncomeToCommon": 3953600000, "trailingEps": 34.72, "forwardEps": 47.27, "pegRatio": 2.93, "enterpriseToRevenue": 7.301, "enterpriseToEbitda": 20.577, "52WeekChange": 0.20544529, "SandP52WeekChange": 0.32311738, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "REGN", "underlyingSymbol": "REGN", "shortName": "Regeneron Pharmaceuticals, Inc.", "longName": "Regeneron Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 670602600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e55aa808-7510-354a-9528-01782e66194d", "messageBoardId": "finmb_33715", "gmtOffSetMilliseconds": -14400000, "currentPrice": 968.01, "targetHighPrice": 1184.0, "targetLowPrice": 710.0, "targetMeanPrice": 1041.59, "targetMedianPrice": 1050.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 23, "totalCash": 10844800000, "totalCashPerShare": 100.918, "ebitda": 4654199808, "totalDebt": 2702899968, "quickRatio": 4.823, "currentRatio": 5.69, "totalRevenue": 13117200384, "debtToEquity": 10.407, "revenuePerShare": 122.935, "returnOnAssets": 0.08494, "returnOnEquity": 0.16258, "freeCashflow": 2769224960, "operatingCashflow": 4593999872, "earningsGrowth": -0.029, "revenueGrowth": 0.006, "grossMargins": 0.52316004, "ebitdaMargins": 0.35481998, "operatingMargins": 0.29202, "financialCurrency": "USD", "trailingPegRatio": 1.5599}